RxDoctor Payments Data

Jaime Santos, MD

Family Medicine · Saint Louis, MONPI 1982895538

Payments from drug & device makers

$3,092in general payments, 2019–2025

Across 189 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$680
  • GSK$385
  • Pfizer$326
  • Novo Nordisk$301
  • Lilly USA, LLC$248
  • Amgen$185
  • plus $966 from 19 others

What the payments were for

  • Food & beverage$3,092100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,092 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$70,395
Medicare patients
183
Services billed
1,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide107$114,249
EliquisApixaban97$93,787
ProliaDenosumab17$28,433
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$25,976
JardianceEmpagliflozin17$23,302
MounjaroTirzepatide13$13,654
MyrbetriqMirabegron11$12,862
Breo ElliptaFluticasone/Vilanterol24$12,660
ArexvyRsvpref3 Antigen/As01e/Pf40$10,856
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$7,879
Atorvastatin Calcium668$6,886
Levothyroxine Sodium436$5,910
AbrysvoRsv Vacc, Pref A And Pref B/Pf20$5,909
VascepaIcosapent Ethyl12$4,090
Omeprazole232$3,465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$301$114,249107 claims
PfizerEliquis, Abrysvo, Paxlovid$326$102,431129 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Anoro Ellipta$385$57,370116 claims
AmgenProlia$185$28,43317 claims
Boehringer IngelheimJardiance$28$23,30217 claims
Lilly USA, LLCMounjaro$248$13,65413 claims
AbbVieSynthroid$171$1,85921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →